APA (7th ed.) Citation

M, B., A, K., S, K., K, J., R, O., J, B., . . . B, P. (2026). Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada. Chronic obstructive pulmonary diseases (Miami, Fla.), 13(3), 184. https://doi.org/10.15326/jcopdf.2025.0687

Chicago Style (17th ed.) Citation

M, Bhutani, Kaplan A, Kayaniyil S, Jamieson K, Ormsby R, Bell J, Bhatt P, Carioto J, and Pyenson B. "Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada." Chronic Obstructive Pulmonary Diseases (Miami, Fla.) 13, no. 3 (2026): 184. https://doi.org/10.15326/jcopdf.2025.0687.

MLA (9th ed.) Citation

M, Bhutani, et al. "Implementation of 2023 Canadian Thoracic Society Guidelines for Single-Inhaler Triple Therapy Could Reduce Exacerbation and Mortality Rates in COPD: PROMETHEUS Canada." Chronic Obstructive Pulmonary Diseases (Miami, Fla.), vol. 13, no. 3, 2026, p. 184, https://doi.org/10.15326/jcopdf.2025.0687.